Humana drops US antitrust claims against Heritage over generic drugs
( August 21, 2026, 15:44 GMT | Official Statement) -- MLex Summary: Humana's stipulation to dismiss with prejudice claims against Heritage Pharmaceuticals and Emcure Pharmaceuticals in litigation alleging a conspiracy to fix the prices of generic drugs has been granted by a Pennsylvania federal judge. In light of that dismissal, Heritage's motion for partial summary judgment is dismissed as moot, US District Judge Cynthia Rufe said in a separate order.See attached files....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.